Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 October 2019 | Story Xolisa Mnukwa | Photo Charl Devenish
Gradstar UFS
The 2019 GradStar programme is all about producing well-rounded students and providing them with opportunities in the world of work, explained Head of UFS Career Services, Belinda Janeke.

Congratulations to the Kovsies top-11 students who made it into the GradStar top-100 programme for 2019!

Each year, 100 South African students are selected through a rigorous four-phase judging process to become part of the GradStar programme. The programme is designed to offer opportunities for employment to previously unrecognised students.

What makes the top 11? 

According to the UFS Head of Career Services, Belinda Janeke, the GradStar programme is all about producing a well-rounded student. Approximately 6 000 applications were received from Kovsies, of which 500 were selected based on a personality test. Another test was given to the 500 students who passed the personality test, after which interviews were conducted to determine the top 100 from the UFS.  

The students who were selected to represent the UFS exhibited the most potential as future leaders in their respective fields. Apart from academic achievement, contestants were evaluated according to their individual soft skills such as motivation, discipline, altruism, and attitude. This combination promised to deliver top candidates for future employers. 

2019 GradStar programme experiences

Throughout the competition, Kovsie contestants were exposed to new people and opportunities to network with various companies in their preferred career fields, where they had the opportunity to share their CVs with potential employers. Contestants were also afforded the opportunity to develop critical problem-solving skills in the world of work. The GradStar top-100 students also have a WhatsApp group where jobs are advertised.

The programme was valuable for the Kovsies; not only did it prepare them for employment, but also provided them with an opportunity for learning and recognising their own strengths and weaknesses as individuals in the working world. 

Congratulations to the Kovsies who made it into the GradStar top 100: 

Mariné du Toit: Bachelor of Social Work
Nyiko Maluleka: Bachelor of Arts, Corporate and Marketing Communication
Bianca Malan: Bachelor of Accounting, Financial Accounting
Boitumelo Mancoe: Master of Business Administration
Kabelo Mashego: Bachelor of Medicine and Bachelor of Surgery (MB ChB)
Kananelo Moletsane: Bachelor of Agriculture
Mudzunga Mukwevho: Bachelor of Accounting, Financial Accounting
Neo Roberts: Bachelor of Science, Information Technology 
Refilwe Maimane: Bachelor of Commerce, Accounting 
Themba Makhoba: Bachelor of Public Administration
Mpolokeng Mmutle: Bachelor of Commerce, Accounting

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept